Pfizer will produce the drug, which targets lung and colorectal cancers, in the US and take a US$100 million stake in China’s 3SBio.
Monday 13 October 2025
scmp - 5 month ago
Chinese biotech firm secures US$6 billion Pfizer deal for cancer drug
Latest News
⁞
Sources